Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2013-08-16 | Mr. Gengos holds an MBA degree from the Anderson School of Management at the University of California, Los Angeles and a BS degree in chemical engineering from the Massachusetts Institute of Technology. |
| 2014-04-30 | Mr. Gengos holds an MBA degree from the Anderson School of Management at the University of California, Los Angeles and a BS degree in chemical engineering from the Massachusetts Institute of Technology. |
| 2015-04-30 | Mr. Gengos holds an MBA degree from the UCLA Anderson School of Management and a BS degree in chemical engineering from the Massachusetts Institute of Technology. His experience includes executive leadership positions in both large and emerging companies, with broad expertise in corporate strategy, business development and transactions. |
| 2015-10-06 | IN WITNESS WHEREOF, the corporation has caused this Certificate to be signed by Andrew Gengos, its President and CEO, this ___ day of ____________, 201_. ImmunoCellular Therapeutics, Ltd. By: Name: Andrew Gengos Title: President and CEO |
| 2016-04-29 | Mr. Gengos holds an MBA degree from the UCLA Anderson School of Management and a BS degree in chemical engineering from the Massachusetts Institute of Technology. |
| 2016-10-04 | Andrew Gengos President and CEO |
Data sourced from SEC filings. Last updated: 2025-07-16